WO2005077322A1 - 液状乳化化粧料 - Google Patents
液状乳化化粧料 Download PDFInfo
- Publication number
- WO2005077322A1 WO2005077322A1 PCT/JP2005/002397 JP2005002397W WO2005077322A1 WO 2005077322 A1 WO2005077322 A1 WO 2005077322A1 JP 2005002397 W JP2005002397 W JP 2005002397W WO 2005077322 A1 WO2005077322 A1 WO 2005077322A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- component
- cosmetic
- emulsified cosmetic
- oil
- present
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/21—Emulsions characterized by droplet sizes below 1 micron
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Definitions
- the present invention relates to a liquid emulsified cosmetic containing a lysophospholipid, an oil, and an electrolyte cosmetic component. More specifically, the present invention relates to a liquid emulsified cosmetic composition which has good storage stability even in the presence of an electrolyte, has a fresh feeling in use, and has a high emollient effect without stickiness.
- electrolytes have been used as emulsifying ingredients for the skin in emulsified cosmetics such as lotions, emulsions, and serums.
- Beauty ingredients include humectants (such as amino acids, sodium lactate, and sodium sodium ribidone carboxylate), anti-inflammatory agents (such as dipotassium dalityrrhizinate), whitening agents (such as L-ascorbic acid 2-magnesium phosphate), and ultraviolet absorbers (such as -Lupenzimidazole sulfonic acid salt) and the like have been used.
- humectants such as amino acids, sodium lactate, and sodium sodium ribidone carboxylate
- anti-inflammatory agents such as dipotassium dalityrrhizinate
- whitening agents such as L-ascorbic acid 2-magnesium phosphate
- ultraviolet absorbers such as -Lupenzimidazole sulfonic acid salt
- Patent Document 1 proposes an emulsified cosmetic containing a specific non-polar oil and a polar oil and having a particle diameter of OO nm or less. It is described that it is preferable to use.
- a water-soluble polymer is used in combination within a range specifically disclosed as an example. There is no particular mention of improving the stability of the ingredients.
- the present invention provides the following component (A) — (D);
- the present invention relates to a liquid emulsified cosmetic containing the same. Further, the present invention relates to the liquid milk cosmetic, wherein the mass ratio of the component (A) to the component (B) is 1: 10-3: 1. Furthermore, the present invention relates to a liquid emulsified cosmetic containing polyoxyethylene sterol ether as the component). Furthermore, the present invention relates to a liquid emulsified cosmetic having a particle size of emulsion droplets of 30 to 300 nm. Furthermore, the present invention relates to a liquid emulsified cosmetic containing 0.1 to 10% by mass of the component (C). Furthermore, the present invention relates to the above liquid emulsified cosmetic containing 15% by mass or more of component (A) lysophosphatidylcholine.
- the cosmetic of the present invention is a liquid emulsified cosmetic having a good storage stability, a fresh feeling of use and a sticky, high emollient effect even when an electrolyte is blended.
- the lysophospholipid of the component (A) used in the present invention is used as an emulsifier in the present invention, Furthermore, the use of lysophospholipids can also impart an emollient effect. In addition, a fresh feeling with less stickiness can be obtained as compared with the case where a normal emulsifier is used.
- the lysophospholipid of the component (A) is used in ordinary cosmetics, and includes, for example, lysophospholipid derived from soybean, hydrogenated lysophospholipid derived from soybean, lysophospholipid derived from egg yolk, and hydrogenated lysophospholipid derived from egg yolk. These lysophospholipids can be used alone or in combination of two or more, if necessary.
- the lysophospholipid used in the present invention may contain a plurality of types of lysophospholipids such as lysophosphatidylcholine and lysophosphatidylethanolanol. Among them, at least lysophosphatidylcholine is preferably contained, more preferably 15% by mass or more, even more preferably 20% by mass or more. When lysophosphatidylcholine is contained in an amount of 15% by mass or more, storage stability is preferred.
- the lysophospholipid of the component (A) used in the present invention is one of enzyme-modified phospholipids in which a 2-position ester bond is hydrolyzed by phospholipase.
- Lysophospholipids unlike phospholipids with double-chain fatty acids, have single-chain fatty acids and therefore have different chemical properties than phospholipids with high HLB.
- lysophospholipid is used as an emulsifier, the stability of the emulsion under acidic conditions and at high temperatures is improved.
- the blending amount of the lysophospholipid as the component (A) is preferably 0.05 to 10% by mass (hereinafter, simply referred to as "%"). 5% is more preferred. Within this range, a sufficient emollient effect and a good feeling in use can be obtained. In addition, storage stability is also good.
- the component (B) oil used in the present invention is an essential component for imparting an emollient effect.
- the oil of the component (B) used in the present invention is not particularly limited as long as it is used for ordinary cosmetics, and it can be used in any form of solid, paste and liquid.
- liquid oils include apogado oil, sesame oil, almond oil, olive oil, kiyoun oil, wheat germ oil, sesame oil, rice germ oil, rice oil, safflower oil, soybean oil, corn oil , Jojoba oil, macadamia nut oil, mink oil, cottonseed oil, coconut oil, liquid lanolin, reduced lanolin, lanolin alcohol, lanolin acetate, lanolin fatty acid isopropyl, squalane, squalene, liquid paraffin, pristane, polyisobutylene, pendesi Lenoic acid, oleic acid, linoleic acid, linolenic acid, isostearic acid, 2-hexyldecyl adipate, N-alkyl glycol monoisostearate, isocetyl isostearate, trimethylolpropane triisostearate, ethylene glycol di-2-ethyl Cetyl 2-ethylhexan
- Hydrogenated castor oil monohydroxystearic acid hydrogenated castor oil, cholesteryl hydroxystearate, dipentaerythritol 12-hydroxystearate, dipentaerythritol stearate, dipentaerythritol Gin esters, N-lauroylue L-glutamate di (cholesteryl'behe-l-octyldodecyl), phytosteryl malt oil and fatty acid phytosteryl, and the like.
- solid oils include carnaupallow, candelilla wax, whale wax, beeswax, ceresin, and the like.
- One or more oil agents can be used as necessary.
- the compounding amount of the oil of the component is 0.5-30%, preferably 2-25%. Within this range, a sufficient emollient effect and good feeling in use can be obtained, and the storage stability is also good.
- the blending mass ratio of the lysophospholipid of the component (A) and the oil of the component (B) is preferably 1: 10-3: 1, 1: 1-10-1. : 1 is more preferred. In this range If it is, storage stability is good, and sufficient emollient effect and good feeling of use without stickiness can be obtained.
- the electrolyte cosmetic component (C) used in the present invention is a cosmetic component that is dermatologically effective on the skin, and may be any component used in ordinary cosmetics. Dermatologically effective cosmetic ingredients are moisturizers, anti-inflammatory agents, whitening agents, UV protection agents, etc., and refer to electrolyte substances.
- examples of humectants include amino acids, lactates such as sodium lactate, pyrrolidone carboxylate such as sodium pyridone carboxylate, and urea;
- examples of anti-inflammatory agents include glycyrrhizinate such as dipotassium glycyrrhizinate Salts;
- examples of whitening agents, ascorbic acid derivatives such as sodium L-ascorbic acid 2-phosphate, magnesium L-ascorbic acid 2-phosphate, darcoside ascorbic acid; and phenylbenzimidazole sulfonates as examples of ultraviolet absorbers And hydroxymethoxybenzophenone sulfonate.
- One or two or more can be used as needed.
- the amount of the electrolyte cosmetic component of component (C) is 0.1%.
- the water of the component (D) used in the present invention is used in ordinary cosmetics.
- the amount of the component (D) in the liquid emulsified cosmetic composition of the present invention is not particularly limited, but is preferably 30 to 99% in order to obtain a fresh feel.
- POE polyoxyethylene
- These POE sterol ethers can be used alone or in combination of two or more as necessary.
- the compounding amount of the POE sterol ether of the component (E) is more preferably 1Z10-3Z4 of the lysophospholipid of the component (A), more preferably 1Z5-1Z2.
- 1Z10-3Z4 of the lysophospholipid of the component (A) is more preferably 1Z5-1Z2.
- the particle size of the liquid emulsified cosmetic of the present invention is preferably 30 to 300 nm. Within this range, storage stability is further improved with less occurrence of tarrying.
- the liquid state of the liquid emulsified cosmetic according to the present invention refers to a liquid having a viscosity at 30 ° C of 11 to 2000 mPa's as measured by a Brookfield rotational viscometer. With the viscosity in this range, a fresh feeling of use can be obtained.
- the liquid emulsified cosmetic of the present invention it is most preferable that the liquid emulsified cosmetic has good storage stability and is not oily and sticky, and is of an oil-in-water type in order to obtain a feeling of use! .
- various components commonly used in cosmetics, quasi-drugs, pharmaceuticals, and the like can be appropriately added to the liquid emulsified cosmetic of the present invention as needed.
- Such optional components include, for example, alcohols, humectants, oily components, emulsifiers, emulsion stabilizers, thickeners, preservatives, powders, pigments, dyes, UV absorbers, PH adjusters, fragrances, Medicinal ingredients, sequestering agents and the like.
- the liquid emulsified cosmetic of the present invention can be manufactured according to a conventional method, or can be manufactured using a high-pressure emulsifier such as a high-pressure homogenizer or a microfluidizer.
- the liquid emulsified cosmetic of the present invention encompasses all skin external preparations, such as quasi-drugs and pharmaceuticals, which are not limited to general skin care cosmetics. It is not limited and can be selected according to the purpose. For example, dosage forms such as milky lotion, lotion, serum, pack, cleansing agent, makeup cosmetic, aerosol and the like can be mentioned.
- Example 18 and Comparative Example 18 Liquid emulsified cosmetic
- Liquid emulsified cosmetics having the compositions shown in Tables 1 and 2 below were produced by the following production methods. Evaluation items for (1) feeling of use (freshness, non-stickiness), (2) emollient effect, (3) storage stability, and (4) particle size of emulsified droplets were evaluated by the following methods, and the results were combined. The results are shown in Tables 1 and 2.
- the particle size of the emulsified droplets of the liquid emulsified cosmetic shown in Table 1 was measured using a COULTER N-4 type (manufactured by BECK MAN COULTER).
- the liquid emulsified cosmetic of the present invention has good storage stability and a fresh feeling of use even when sodium lactate (humectant), which is an electrolyte cosmetic component, is present. Thus, it was a liquid emulsified cosmetic having a high emollient effect without stickiness.
- the viscosities of the present Example and Comparative Example were 11 to 2000 mPa's at 30 ° C.
- Example 9 emollients having good storage stability, a fresh feeling of use, and no stickiness even in the presence of the electrolyte cosmetic ingredient L-ascorbic acid diphosphate magnesium (whitening agent). It was a highly effective whitening lotion.
- the viscosity in this example was 10 mPa's at 30 ° C.
- the particle diameter of the emulsified droplet of this example was 100 to 250 nm.
- Example 10 even if sodium lactate and sodium pyrrolidone carboxylate (humectant), which are electrolyte cosmetic components, are present, storage stability is good, fresh feeling is obtained, and stickiness is reduced. It was an emollient serum with a high emollient effect.
- the viscosity in this example was 20 mPa's.
- the particle diameter of the emulsified droplet in this example is 50 to 250 nm.
- Example 11 even if dipotassium glycyrrhizinate (an anti-inflammatory agent) as an electrolyte was present,
- the emulsion had good storage stability, a fresh feeling of use, and a high emollient effect without stickiness.
- the viscosity in this example was 25 mPa's.
- the particle diameter of the emulsified droplet of this example was 40 to 280 nm.
- Example 12 shows that even when phenylbenzimidazole sulfonic acid (ultraviolet ray absorbent), which is an electrolyte cosmetic component, is present, storage stability is good, a fresh feeling in use, and a sticky emollient. It was a very effective sunscreen lotion.
- the viscosity of this example was 100 mPa's. Further, the particle size of this example was 80 to 200 nm.
- Example 13 shows that even when N-acetyl-L-glutamic acid and L-serine (humectant), which are electrolyte cosmetic components, are present, the storage stability is good, the use feeling is fresh, and the emollient is sticky. It was a highly effective cleansing lotion.
- the viscosity of this example was 1500 mPa's. Further, the particle size of this example was 50 to 250 nm.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200580004705XA CN1917850B (zh) | 2004-02-18 | 2005-02-17 | 液态乳化化妆品 |
KR1020067018930A KR101223302B1 (ko) | 2004-02-18 | 2005-02-17 | 액상 유화 화장료 |
JP2005518044A JP4904055B2 (ja) | 2004-02-18 | 2005-02-17 | 液状乳化化粧料 |
HK07106035.7A HK1098391A1 (en) | 2004-02-18 | 2007-06-06 | Liquid emulsion cosmetic |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-040789 | 2004-02-18 | ||
JP2004040789 | 2004-02-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005077322A1 true WO2005077322A1 (ja) | 2005-08-25 |
Family
ID=34857901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/002397 WO2005077322A1 (ja) | 2004-02-18 | 2005-02-17 | 液状乳化化粧料 |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP4904055B2 (ja) |
KR (1) | KR101223302B1 (ja) |
CN (1) | CN1917850B (ja) |
HK (1) | HK1098391A1 (ja) |
TW (1) | TW200603833A (ja) |
WO (1) | WO2005077322A1 (ja) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007269634A (ja) * | 2006-03-30 | 2007-10-18 | Kose Corp | 2剤混合型皮膚外用剤 |
JP2009107932A (ja) * | 2007-10-26 | 2009-05-21 | Fancl Corp | 乳化化粧料 |
JPWO2009020067A1 (ja) * | 2007-08-03 | 2010-11-04 | 株式会社コーセー | 液状化粧料 |
JP2011213601A (ja) * | 2010-03-31 | 2011-10-27 | Kose Corp | 水中油型乳化化粧料 |
JP2013082643A (ja) * | 2011-10-07 | 2013-05-09 | Mikimoto Pharmaceut Co Ltd | O/w型エマルジョン |
JP2013209319A (ja) * | 2012-03-30 | 2013-10-10 | Kose Corp | アスコルビン酸誘導体が配合された水中油型乳化組成物 |
JP2014193823A (ja) * | 2013-03-28 | 2014-10-09 | Kose Corp | 化粧料 |
JP2021014435A (ja) * | 2019-07-12 | 2021-02-12 | 株式会社コーセー | バイセル構造体を含有する組成物 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6914654B2 (ja) * | 2016-12-28 | 2021-08-04 | ライオン株式会社 | 口腔用組成物 |
KR20190075408A (ko) | 2017-12-21 | 2019-07-01 | 탑월드(주) | 천연 오일 화장료 조성물 |
KR101953559B1 (ko) * | 2018-09-03 | 2019-03-04 | 주식회사 펠리즈코스 | 수중유형 화장료 조성물 및 그 제조방법 |
CN115612321B (zh) * | 2022-09-27 | 2024-01-19 | 常州君合科技股份有限公司 | 一种环保型水性锌铝防腐涂液及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03196833A (ja) * | 1989-12-27 | 1991-08-28 | Iwase Kosufua Kk | 親水性ゲル状組成物および水中油型乳化組成物 |
JPH06279254A (ja) * | 1992-07-15 | 1994-10-04 | Pola Chem Ind Inc | 化粧料用乳化組成物の製造方法 |
JP2000226308A (ja) * | 1998-12-04 | 2000-08-15 | Shiseido Co Ltd | 表皮細胞におけるラミニンの産生促進剤 |
JP2003235462A (ja) * | 2002-02-08 | 2003-08-26 | Asahi Denka Kogyo Kk | 乳化活性物質及び水中油型乳化脂 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6341411A (ja) * | 1986-08-07 | 1988-02-22 | Kyowa Hakko Kogyo Co Ltd | 皮膚外用剤 |
JP3489703B2 (ja) * | 1995-10-23 | 2004-01-26 | 株式会社ノエビア | 微細エマルション組成物 |
JP3434115B2 (ja) * | 1996-02-29 | 2003-08-04 | 株式会社資生堂 | 乳化化粧料 |
JPH1118697A (ja) * | 1997-07-09 | 1999-01-26 | Toyo Beauty Kk | 含油ゲル状組成物及び水中油型乳化組成物 |
JP2001031551A (ja) * | 1999-07-15 | 2001-02-06 | Shiseido Co Ltd | 肌荒れ防止・改善用皮膚外用剤 |
JP2001039850A (ja) * | 1999-07-27 | 2001-02-13 | Shiseido Co Ltd | コラーゲンゲル収縮促進剤 |
JP2002138014A (ja) * | 2000-10-31 | 2002-05-14 | Noevir Co Ltd | 微細エマルション組成物 |
JP2003063996A (ja) * | 2001-08-23 | 2003-03-05 | 禎秀 ▲廣▼▲崎▼ | 皮膚外用剤 |
JP3731547B2 (ja) * | 2002-02-21 | 2006-01-05 | 不二製油株式会社 | 組織状蛋白及びこれを用いた加工食品の製造法 |
-
2005
- 2005-02-16 TW TW094104519A patent/TW200603833A/zh unknown
- 2005-02-17 WO PCT/JP2005/002397 patent/WO2005077322A1/ja active Application Filing
- 2005-02-17 JP JP2005518044A patent/JP4904055B2/ja active Active
- 2005-02-17 CN CN200580004705XA patent/CN1917850B/zh active Active
- 2005-02-17 KR KR1020067018930A patent/KR101223302B1/ko active IP Right Grant
-
2007
- 2007-06-06 HK HK07106035.7A patent/HK1098391A1/xx unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03196833A (ja) * | 1989-12-27 | 1991-08-28 | Iwase Kosufua Kk | 親水性ゲル状組成物および水中油型乳化組成物 |
JPH06279254A (ja) * | 1992-07-15 | 1994-10-04 | Pola Chem Ind Inc | 化粧料用乳化組成物の製造方法 |
JP2000226308A (ja) * | 1998-12-04 | 2000-08-15 | Shiseido Co Ltd | 表皮細胞におけるラミニンの産生促進剤 |
JP2003235462A (ja) * | 2002-02-08 | 2003-08-26 | Asahi Denka Kogyo Kk | 乳化活性物質及び水中油型乳化脂 |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007269634A (ja) * | 2006-03-30 | 2007-10-18 | Kose Corp | 2剤混合型皮膚外用剤 |
JPWO2009020067A1 (ja) * | 2007-08-03 | 2010-11-04 | 株式会社コーセー | 液状化粧料 |
JP5571384B2 (ja) * | 2007-08-03 | 2014-08-13 | 株式会社コーセー | 液状化粧料 |
JP2009107932A (ja) * | 2007-10-26 | 2009-05-21 | Fancl Corp | 乳化化粧料 |
JP4659810B2 (ja) * | 2007-10-26 | 2011-03-30 | 株式会社ファンケル | 乳化化粧料 |
JP2011213601A (ja) * | 2010-03-31 | 2011-10-27 | Kose Corp | 水中油型乳化化粧料 |
JP2013082643A (ja) * | 2011-10-07 | 2013-05-09 | Mikimoto Pharmaceut Co Ltd | O/w型エマルジョン |
JP2013209319A (ja) * | 2012-03-30 | 2013-10-10 | Kose Corp | アスコルビン酸誘導体が配合された水中油型乳化組成物 |
JP2014193823A (ja) * | 2013-03-28 | 2014-10-09 | Kose Corp | 化粧料 |
JP2021014435A (ja) * | 2019-07-12 | 2021-02-12 | 株式会社コーセー | バイセル構造体を含有する組成物 |
JP7321015B2 (ja) | 2019-07-12 | 2023-08-04 | 株式会社コーセー | バイセル構造体を含有する組成物 |
Also Published As
Publication number | Publication date |
---|---|
HK1098391A1 (en) | 2007-07-20 |
KR20060128008A (ko) | 2006-12-13 |
CN1917850B (zh) | 2011-04-06 |
CN1917850A (zh) | 2007-02-21 |
TW200603833A (en) | 2006-02-01 |
JPWO2005077322A1 (ja) | 2007-10-18 |
JP4904055B2 (ja) | 2012-03-28 |
TWI348917B (ja) | 2011-09-21 |
KR101223302B1 (ko) | 2013-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5571384B2 (ja) | 液状化粧料 | |
WO2005077322A1 (ja) | 液状乳化化粧料 | |
JP5047369B2 (ja) | O/w微細エマルション外用剤の製造方法 | |
JP4709320B2 (ja) | O/w乳化組成物の製造方法 | |
JP4495941B2 (ja) | 水中油型乳化化粧料 | |
JP6281744B2 (ja) | 水中油型乳化化粧料 | |
WO2005051334A1 (ja) | 水中油型乳化化粧料及びその製造方法 | |
JP5491917B2 (ja) | 乳化化粧料 | |
JP5833810B2 (ja) | 水中油型乳化化粧料 | |
JP5203623B2 (ja) | 水中油型乳化化粧料 | |
JP5260482B2 (ja) | 水中油型乳化化粧料 | |
JP5117591B2 (ja) | 油中水型乳化化粧料 | |
JP6133618B2 (ja) | 油中水型乳化組成物 | |
JP5869296B2 (ja) | 油中水型乳化組成物 | |
JP6850599B2 (ja) | 水中油型乳化組成物および皮膚外用剤 | |
JP5503175B2 (ja) | クラッキングエアゾール組成物 | |
JP2006241038A (ja) | 乳化化粧料 | |
JP5824323B2 (ja) | 油中水型乳化組成物 | |
JP5437552B2 (ja) | 2剤混合型皮膚外用剤 | |
JP2008088092A (ja) | 液状水中油型乳化化粧料 | |
JP5238139B2 (ja) | 液状乳化化粧料 | |
JP2007269668A (ja) | 水中油型美白化粧料 | |
JP2007269664A (ja) | 水中油型乳化化粧料 | |
JP2007262038A (ja) | 水中油型液状化粧料 | |
JPH04173715A (ja) | 乳化化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 200580004705.X Country of ref document: CN Ref document number: 2005518044 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067018930 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067018930 Country of ref document: KR |
|
122 | Ep: pct application non-entry in european phase |